Yonhap Infomax NewsApr 14, 2025
Trump signals imminent tariffs on imported drugs, potentially reshaping pharmaceutical trade and domestic manufacturing landscape
#YonhapInfomax #Trump #ImportedDrugs #Tariffs #PharmaceuticalTrade #DomesticManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=58625
Trump - 'Tariffs on Imported Drugs... Not Too Distant Future'

Trump signals imminent tariffs on imported drugs, potentially reshaping pharmaceutical trade and domestic manufacturing landscape

Yonhap Infomax
Yonhap Infomax NewsApr 2, 2025
US pharmaceutical giants face potential tariff risks as Trump administration considers imposing up to 25% tariffs on imported drugs, with Merck, AbbVie, Amgen, and Pfizer identified as most vulnerable.
#YonhapInfomax #TrumpTariffs #PharmaceuticalIndustry #Merck #AbbVie #ImportedDrugs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56730
Trump's Tariffs Threaten US Pharmaceutical Industry - Merck, AbbVie, Amgen Face Higher Risks

US pharmaceutical giants face potential tariff risks as Trump administration considers imposing up to 25% tariffs on imported drugs, with Merck, AbbVie, Amgen, and Pfizer identified as most vulnerable.

Yonhap Infomax